Welcome to our dedicated page for Avepoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint’s shift to a recurring-revenue SaaS model means critical numbers—ARR growth, net retention, cloud marketplace expansion—are buried deep in its regulatory reports. Browsing a 300-page annual filing just to confirm Microsoft partnership royalties can feel impossible. Investors, analysts, and even customers ask for “AvePoint SEC filings explained simply,” so they can track how data-governance subscriptions translate into cash flow. Miss a footnote and you might overlook deferred revenue tied to multi-year Microsoft 365 licenses.
Stock Titan’s AI reads every AvePoint quarterly earnings report 10-Q filing the moment it hits EDGAR, flags changes in deferred revenue, and renders the ratios in plain English. The same technology turns the AvePoint annual report 10-K simplified into a crisp overview of segment performance and customer-count trends. Sudden cloud outages or partnership updates? Our dashboard delivers AvePoint 8-K material events explained alongside redlined text, so you see exactly what changed. For governance watchers, we surface AvePoint proxy statement executive compensation tables with side-by-side year-over-year comparisons.
Curious about insider sentiment? Receive push alerts on AvePoint insider trading Form 4 transactions within seconds. Our system captures AvePoint Form 4 insider transactions real-time, tags each AvePoint executive stock transactions Form 4 entry, and links it back to the related disclosure. Interactive charts power AvePoint earnings report filing analysis, letting you compare ARR guidance against actual bookings. Whether you’re building a DCF or checking compliance exposure, understanding AvePoint SEC documents with AI means fewer surprises and faster, evidence-based decisions.
Form 4 Overview – AvePoint, Inc. (AVPT)
Director Janet Schijns reported an equity transaction dated 20 June 2025. The filing shows the acquisition of 9,744 shares of AvePoint common stock (classified as restricted stock units, RSUs) at a stated price of $17.96 per share under the company’s 2021 Equity Incentive Plan. The RSUs represent a contingent right to receive one share of common stock for each unit upon vesting.
Vesting & Ownership
- 100 % of the RSUs vest on 1 June 2026, subject to the director’s continued service.
- Post-transaction beneficial ownership rises to 89,801 shares, held directly.
No derivative securities (options, warrants, etc.) were reported in Table II. The transaction was coded “A” (acquisition) and signed by Attorney-in-Fact Brian Michael Brown on 23 June 2025.
Investor Takeaways
- The filing indicates continued board-level alignment with shareholders through additional equity exposure.
- Because the award is in the form of RSUs rather than an open-market cash purchase, cash outlay by the insider is minimal; nevertheless, the grant’s delayed vesting may aid long-term retention.
AvePoint, Inc. (AVPT) filed a Form 4 disclosing that director John Chi On Ho received 9,744 shares of common stock in the form of restricted stock units (RSUs) on 20 June 2025 under the company’s 2021 Equity Incentive Plan. The transaction is coded “A,” indicating an acquisition rather than a disposition. The RSUs carry a grant date value that references a $17.96 share price, but no cash changed hands because the units were awarded, not bought on the open market.
Following the grant, Ho’s total beneficial ownership rose to 4,295,768 shares, reinforcing a substantial insider stake. Per the accompanying footnotes, 100% of these RSUs will vest on 1 June 2026, contingent on Ho’s continued service as a director. No derivative securities, options, or additional equity instruments were reported. The filing contains no information on company earnings, operations, or other material events; it is strictly a disclosure of insider equity compensation.
For investors, the award marginally increases insider alignment but is not large enough relative to the existing 4.3 million-share holding—or AvePoint’s overall float—to be considered materially dilutive or a strong buy signal. The absence of open-market purchases limits the direct market-sentiment read-through. Overall, the filing is routine and has limited impact on the investment thesis, though it confirms ongoing board engagement and adherence to compensation schedules.
FAQ
What is the current stock price of Avepoint (AVPT)?
What is the market cap of Avepoint (AVPT)?
